...
Definexmltable |
---|
Multiple | true |
---|
Level | Dataset |
---|
Purpose | Analysis |
---|
|
Dataset NameLabel | Description | Class | Structure | Purpose | Keys | Class Location | DocumentationLocation |
---|
ADSL | Subject-Level Analysis Dataset | SUBJECT LEVEL ANALYSIS DATASET | One record per subject. | Analysis | USUBJID | SUBJECT LEVEL ANALYSIS DATASET | ADaMIG | adsl.xpt | ADSL.SAS | ADCVNTP | CV EF and NT-proBNP Analysis | BASIC DATA STRUCTURE | One record per subject per analysis visit per parameter. | Analysis | USUBJID, AVISITN, PARAMN | BASIC DATA STRUCTURE | adcvntp.xpt | SAPAnalysis Dataset Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-4 |
---|
|
| adcvntp.xpt | ADCVCMR | CV CMR Ejection Fraction Analysis | BASIC DATA STRUCTURE | One record per subject per analysis visit per parameter. | Analysis | USUBJID, AVISITN, PARAMN | BASIC DATA STRUCTURE | | adcvcmr.xpt | |
|
ADSL
The ADSL contains subject characteristics and covariates that are important for analyses. Stratification variables can be created in the ADSL to subset the data. More than one SDTM dataset may be used as input to the ADSL. This is a simplified example ADSL dataset; the ADaMIG should be referenced for additional variables. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-2 |
---|
|
...
Definexmltable |
---|
Dataset | ADSL |
---|
Level | Variable |
---|
Purpose | Analysis |
---|
Name | Variable |
---|
|
Variable Name | Variable Label | Type | Codelist/Controlled Terms |
---|
/Format/Derivation/Comment |
---|
STUDYID | Study Identifier | Chartext |
| Predecessor: DM.STUDYID | USUBJID | Unique Subject Identifier | Chartext |
| Predecessor: DM.USUBJID | BRTHDT | Date of Birth | Numinteger | date9. | Derived: Date portion of DM.BRTHDTC converted to numeric and displayed in a format such as date9. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-5 |
---|
| | AAGE | Analysis Age | Numfloat |
| Derived: Age as screening, computed by DM.RFICDTC - BRTHDTC as continuous variable. Note that some countries do not allow capturing date of birth, so this could be computed by capturing age in years and months on a CRF. | AGE | Age | Numinteger |
| Predecessor: DM.AGE | AGEU | Age Units | Chartext | YEARS | Predecessor: DM.AGEU | SEX | Sex | Chartext | (SEX) | Predecessor: DM.SEX | RACE | Race | Numtext | (RACE) | Predecessor: DM.RACE | TRTSDT | Date of First Exposure to Treatment | Numinteger | date9. | Derived: Date portion of DM.RFSTDTC converted to numeric and displayed in a format such as date9. | RFICDT | | Numinteger | date9. | Derived: Date portion of DM.RFICDTC converted to numeric and displayed in a format such as date9. | DTHDT | | Numinteger | date9. | Derived: Date portion of DM.DTHDT Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-6 |
---|
| converted to numeric and displayed in a format such as date9. | DTHFL | | Chartext | Y | Predecessor: DM.DTHFL | TRT01P | Planned Treatment for Period 01 | Chartext | Drug A, Drug B | Predecessor: DM.ARM. May be changed to lower case or more descriptive term for use in tables and listings. | TRT01A | Actual Treatment for Period 01 | Chartext | Drug A, Drug B | Predecessor: DM.ACTARM. Note: Actual treatment matches planned treatment unless there is a reason subject does not take planned drug. | ITTFL | Intent-To-Treat Population Flag | Chartext | Y; N | Derived: Derive the intent-to-treat population as per the protocol and SAP. | ACEINHFL | ACE Inhibitor Medications Flag | Chartext | Y; N | Derived: Select a list of ACE inhibitor medications from concomitant medications (CM) domain as per SAP or protocol. Set to "Y" if these medications were taken during the study, and "N" if they are absent. Can be used to subset or to exclude the population who took ACE inhibitors. | HEIGHTSC | Height (cm) at Screening | Numfloat |
| Predecessor: Set to VS.VSSTRESN where VS.VSTESTCD = "HEIGHT" and VISITNUM= 1 (or screening visit). | WEIGHTSC | Weight (kg) at Screening | Numfloat |
| Predecessor: Set to VS.VSSTRESN where VS.VSTESTCD = "WEIGHT" and VISITNUM = 1 (or screening visit). | BSASC | Body Surface Area at Screening | Numfloat |
| Derived: Select where VISITNUM = 1 (or screening visit). Compute from HEIGHT and WEIGHT, using the Du Bois method. BSA = 0.007184 × W0.425 × H0.725 There are multiple methods for calculating BSA (e.g., Du Bois, Mosteller, Haycock, Gehan & George, Boyd, Fujimoto, Takahira, Schlich); the study protocol should describe which to use. |
|
Dataset wrap |
---|
|
Dataset2 |
---|
| Row | STUDYID | USUBJID | BRTHDT | AAGE | AGE | AGEU | SEX | RACE | TRTSDT | RFICDT | DTHDT | DTHFL | TRT01P | ITTFL | ACEINHFL | HEIGHTSC | WEIGHTSC | BSASC |
---|
1 | DMD-EFLGE | DMD-EF-01-101 | 07FEB2010 | 12.3 | 12 | YEARS | M | BLACK OR AFRICAN AMERICAN | 16JUN2022 | 16JUN2022 |
|
| Drug A | Y | Y | 119 | 20 | 0.82 | 2 | DMD-EFLGE | DMD-EF-01-101 | 01MAY2008 | 14.1 | 14 | YEARS | M | ASIAN | 13JUN2022 | 13JUN2022 |
|
| Drug A | Y | Y | 115 | 30 | 0.95 | 3 | DMD-EFLGE | DMD-EF-01-101 | 10JUL2003 | 19.0 | 19 | YEARS | M | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | 15JUL2022 Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-7 |
---|
|
| 15JUL2022 |
|
| Drug B | Y | N | 140 | 45 | 1.30 | 4 | DMD-EFLGE | DMD-EF-01-101 | 15JAN1999 | 23.7 | 23 | YEARS | M | WHITE | 06SEP2022 | 06SEP2022 | 23NOV2023 | Y | Drug B | Y | Y | 132 | 42 | 1.21 |
|
|
...
Definexmltable |
---|
Dataset | ADCVNTP |
---|
Level | Value |
---|
Purpose | Analysis |
---|
OID | AVAL |
---|
|
Dataset | Variable | Where | Type | Origin | Derivation/Comment |
---|
ADCVNTP | AVAL | PARAMCD in ("LVEF_C", "RVEF_C") | NumSet to Predecessor: CV.CVSTRESN | ADCVNTP | AVAL | PARAMCD = "BNPPRONT" | NumSet to Predecessor: LB.LBSTRESN where LB.LBTESTCD = "BNPPRONT" | ADCVNTP | CHGCAT1 | PARAMCD in ("LVEF_C", "RVEF_C") | text | Char
| Derived: Categorize the value of CHGCAT1 as follows: If CHG >= 5.00 THEN CHGCAT1 = "Decline >=5%". Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-9 |
---|
|
Else if CHG not missing and CHG < 5.00 THEN CHGCAT1 = "Decline <5%" Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-10 |
---|
|
| ADCVNTP | CHGCAT1 | PARAMCD = "BNPPRONT" | Chartext |
| Derived: Categorize the value of CHCAT1 as follows: "Increase >100 ng/L"; "Increase <=100 ng/L"; "No increase" Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-11 |
---|
|
|
|
Definexmltable |
---|
Dataset | ADCVNTP |
---|
Level | Variable |
---|
Purpose | Analysis |
---|
Name | Variable |
---|
|
Variable Name | Variable Label | Type | Codelist/Controlled Terms |
---|
/Format/Derivation/Comment |
---|
STUDYID | Study Identifier | Chartext |
| Predecessor: CV.STUDYID | USUBJID | Unique Subject Identifier | Chartext |
| Predecessor: CV.USUBJID | BRTHDT | Date of Birth | NumDate9date9. | Predecessor: ADSL.BRTHDT | AAGE | Analysis Age | Numfloat |
| Predecessor: ADSL.AAGE | AGEU | Age Unit | CharYEARS |
|
Predecessor: ADSL.AGEU | SEX | Sex | Chartext | (SEX) | Predecessor: ADSL.SEX Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-16 |
---|
|
| RACE | Race | Numtext | (RACE) | Predecessor: ADSL.RACE | TRTSDT | Date of First Exposure to Treatment | Numinteger | date9 | Predecessor: ADSL.TRTSDT | TRT01P | Planned Treatment for Period 01 | Chartext | Drug A; Drug B | Predecessor: ADSL.TRT01P | TRT01A | Actual Treatment for Period 01 | Chartext | Drug A; Drug B | Predecessor: ADSL.TRT01A | ITTFL | Intent-To-Treat Population Flag | Chartext | Y; N | | HEIGHT | Height (cm) | Numfloat |
| Set to VS.VSSTRESN where VS.VSTEST = "HEIGHT" by visit. | WEIGHT | Weight (kg) | Numfloat |
| Set to VS.VSSTRESN where VS.VSTEST = "WEIGHT" by visit. | BSA | Body Surface Area (m2) | Numfloat |
| Derived: Compute from HEIGHT and WEIGHT at each visit, using the Du Bois method. BSA = 0.007184 × W0.425 × H0.725 There are multiple methods for calculating BSA; the study protocol should describe which to use. | ACEINHFL | ACE Inhibitor Medications Flag | Chartext | Y; N | Predecessor: ADSL.,ACEINHFL | PARAM | Parameter | Chartext | Left Ventricular Ejection Fraction, Cal (%); Right Ventricular Ejection Fraction, Cal (%); N-Terminal ProB-type Natriuretic Peptide (ng/L) | Predecessor: CV.CVTEST LB.LBTEST | PARAMCD | Parameter Code | Chartext | LVEF_C; RVEF_C; BNPPRONT | Predecessor: CV.CVTESTCD LB.LBTESTCD | PARAMN | Parameter (N) | Numinteger | 1; 2; 3; | Assigned: Number PARAMCD as follows: LVEF_C = "1" RVEF_C = "2" BNPPRONT = "3" | AVAL | Analysis Value | Numfloat |
| See Parameter Value Metadata | AVISIT | Analysis Visit | Chartext | Visit 1 (Baseline); Visit 6 (1 Year) | If CV.VISIT = "VISIT 1" then AVISIT = "Visit 1 (Baseline)". If CV.VISIT = "VISIT 6" then AVISIT = "Visit 6 (1 Year)". | AVISITN | Analysis Visit (N) | Numinteger | 1; 6 | Predecessor: CV.VISITNUM LB.VISITNUM | VISIT | Visit | Numinteger | VISIT 1; VISIT 6 | Predecessor: CV.VISIT LB.VISIT | ADT | Analysis Date | Numinteger | date9. | Date portion of CV.CVDTC or LB.LBDTC converted to numeric and displayed in a format such as date9. | ABLFL | Baseline Record Flag | Chartext | Y | Derived: If CV.VISIT = "VISIT 1" then ABLFL = "Y". | BASE | Baseline Value | Numfloat |
| Derived: Set BASE to AVAL from the record for that subject and parameter where ABLFL = "Y". Populate BASE for additional visits by merging the value of BASE in the baseline record by USUBJID and PARAMCD. | CHG | Change from Baseline | Numfloat |
| Derived: Compute CHG = AVAL - BASE for that record. Only compute for post-baseline records. | PCHG | Percent Change from Baseline | Numfloat |
| Derived: Compute PCHG = (CHG / BASE) * 100. Only compute for post-baseline records. | CHGCAT1 | Change from Baseline Category 1 | Chartext | Decline >=5%; Decline <5%; Increase GT 100 ng/L | See Parameter Value Metadata | SRCDOM | Source Data | Chartext | CV; LB | Assigned: Set to the SDTM domain name that relates to the analysis value. | SRCVAR | Source Variable | Chartext |
| Assigned: Set to the SDTM variable that | relates to relates to the analysis value. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-12 |
---|
|
| SRCSEQ | Source Sequence Number | integer | Num
| Predecessor: CV.CVSEQ LB.LBSEQ Set to the SDTM domain sequence number that relates to the analysis value. |
|
Dataset wrap |
---|
|
Dataset2 |
---|
| Row | STUDYID | USUBJID | AAGE | AGEU | SEX | RACE | TRT01P | TRT01A | ITTFL | HEIGHT | WEIGHT | BSA | ACEINHFL | PARAM | PARAMCD | PARAMN | AVAL | AVISIT | AVISITN | VISIT | ADT | ABLFL | BASE | CHG | PCHG | CHGCAT1 | SRCDOM | SRCVAR | SRCSEQ |
---|
1 | DMD-EFLGE | DMD-EF-01-101 | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Drug A | Y | 119 | 20 | 0.82 | Y | Left Ventricular Ejection Fraction, Cal (%) | LVEF_C | 1 | 67 | Visit 1 (Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 67 |
|
|
| CV | CVTESTCD Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TAUGDMDCIS-13 |
---|
|
| 3 | 2 | DMD-EFLGE | DMD-EF-01-101 | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Drug A | Y | 119 | 20 | 0.82 | Y | Right Ventricular Ejection Fraction, Cal (%) | RVEF_C | 2 | 74 | Visit 1 (Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 74 |
|
|
| CV | CVTESTCD | 7 | 3 | DMD-EFLGE | DMD-EF-01-101 | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Drug A | Y | 119 | 20 | 0.82 | Y | N-Terminal ProB-type Natriuretic Peptide (ng/L) | BNPPRONT | 3 | 40 | Visit 1 (Baseline) | 1 | VISIT 1 | 16MAY2022 | Y | 40 |
|
|
| LB | LBTESTCD | 1 | 4 | DMD-EFLGE | DMD-EF-01-101 | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Drug A | Y | 132 | 32 | 1.08 | Y | Left Ventricular Ejection Fraction, Cal (%) | LVEF_C | 1 | 60 | Visit 6 (1 Year) | 6 | VISIT 6 | 06APR2023 |
| 67 | -7 | -10.447761 | Decline >=5.0% | CV | CVTESTCD | 11 | 5 | DMD-EFLGE | DMD-EF-01-101 | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Drug A | Y | 132 | 32 | 1.08 | Y | Right Ventricular Ejection Fraction, Cal (%) | RVEF_C | 2 | 61 | Visit 6 (1 Year) | 6 | VISIT 6 | 06APR2023 |
| 74 | -13 | -17.567568 | Decline >=5.0% | CV | CVTESTCD | 15 | 6 | DMD-EFLGE | DMD-EF-01-101 | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Drug A | Y | 132 | 32 | 1.08 | Y | N-Terminal ProB-type Natriuretic Peptide (ng/L) | BNPPRONT | 3 | 900 | Visit 6 (1 Year) | 6 | VISIT 6 | 06APR2023 |
| 40 | 860 | 2,150 | Increase >100 ng/L | LB | LBTESTCD | 2 |
|
|
...
Definexmltable |
---|
Dataset | ADCVCMR |
---|
Level | Variable |
---|
Purpose | Analysis |
---|
Name | Variable |
---|
|
Variable Name | Variable Label | Type | Codelist/Controlled Terms |
---|
/Format/Derivation/Comment |
---|
STUDYID | Study Identifier | Chartext |
| Predecessor: ADCVNTP.STUDYID | USUBJID | Unique Subject Identifier | Chartext |
| Predecessor: ADCVNTP.USUBJID | BRTHDT | Date of Birth | Numinteger | date9. | Predecessor: ADCVNTP.BRTHDT | AAGE | Analysis Age | Numfloat |
| Predecessor: ADCVNTP.AAGE | AGEU | Age Unit | CharADCVNTPLPredecessor: ADCVNTP.AGEU | SEX | Sex | CharADCVNTPLPredecessor: ADCVNTP.SEX | RACE | Race | NumADCVNTPLPredecessor: ADCVNTP.RACE | TRTSDT | Date of First Exposure to Treatment | Num | date9. | Predecessor: ADCVNTP.TRTSDT | TRT01P | Planned Treatment for Period 01 | Chartext | Drug A; Drug B | Predecessor: ADCVNTP.TRT01P | ITTFL | Intent-To-Treat Population Flag | Chartext | Y; N | Predecessor: ADCVNTP.ITTFL | BSA | Body Surface Area (m2) | Numfloat |
| Predecessor: ADCVNTP.BSA | ACEINHFL | ACE Inhibitor Medications Flag | Chartext | Y; N | Predecessor: ADCVNTP.ACEINHFL | BNPPRONT | Num
| integer |
| Derived: BNPPRONT = AVAL where PARAMCD = ADCVNTP.BNPPRONT, and merge by USUBJID and AVISITN. Note: There are many ways to add this including transposing the data. | PARAM | Parameter | Chartext | Left Ventricular Ejection Fraction, Cal (%); Right Ventricular Ejection Fraction, Cal (%) | Predecessor: ADCVNTP.PARAM | PARAMCD | Parameter Code | Chartext | LVEF_C; RVEF_C | Predecessor: ADCVNTP.PARAMCD | PARAMN | Parameter (N) | Numinteger |
| Predecessor: ADCVNTP.PARAMN | AVAL | Analysis Value | Numf;oat |
| Predecessor: ADCVNTP.AVAL | AVISIT | Analysis Visit | Chartext | Visit 1 (Baseline); Visit 6 (1 Year) | Predecessor: ADCVNTP.AVISIT | AVISITN | Analysis Visit (N) | Numinteger | 1; 6 | Predecessor: ADCVNTP.AVISITN | ADT | Analysis Date | Numfloat | date9. | Predecessor: ADCVNTP.ADT | ABLFL | Baseline Record Flag | Chartext | Y | Predecessor: ADCVNTP.ABLFL | BASE | Baseline Value | Numfloat |
| Predecessor: ADCVNTP.BASE | CHG | Change from Baseline | Numfloat |
| Predecessor: ADCVNTP.CHG | PCHG | Percent Change from Baseline | Numfloat |
| Predecessor: ADCVNTP.PCHG | CHGCAT1 | Change from Baseline Category 1 | Chartext | Decline >=5.0%; Decline <5.0%; Increase >100 ng/L | Predecessor: ADCVNTP.CHGCAT1 |
|
Dataset wrap |
---|
|
Dataset2 |
---|
| Row | STUDYID | USUBJID | BRTHDT | TRT01P | AAGE | AGU | SEX | RACE | TRT01A | ITTFL | BSA | ACEINHFL | BNPPRONT | PARAM | PARAMCD | PARAMN | AVAL | AVISIT | AVISITN | ADT | ABLFL | BASE | CHG | PCHG | CHGCAT1 |
---|
1 | DMD-EFLGE | DMD-EF-01-101 | 07FEB2010 | Drug A | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Y | 0.82 | Y | 40 | Left Ventricular Ejection Fraction, Cal (%) | LVEF_C | 1 | 70 | Visit 1 (Baseline) | 1 | 16MAY2022 | Y | 70 |
|
|
| 2 | DMD-EFLGE | DMD-EF-01-101 | 07FEB2010 | Drug A | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Y | 0.82 | Y | 40 | Right Ventricular Ejection Fraction, Cal (%) | RVEF_C | 2 | 75 | Visit 1 (Baseline) | 1 | 16MAY2022 | Y | 75 |
|
|
| 3 | DMD-EFLGE | DMD-EF-01-101 | 07FEB2010 | Drug A | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Y | 1.08 | Y | 900 | Left Ventricular Ejection Fraction, Cal (%) | LVEF_C | 1 | 65 | Visit 6 (1 Year) | 6 | 06APR2023 |
| 70 | -5 | -10.447761 | Decline >=5.0% | 4 | DMD-EFLGE | DMD-EF-01-101 | 07FEB2010 | Drug A | 12.3 | YEARS | M | BLACK OR AFRICAN AMERICAN | Drug A | Y | 1.08 | Y | 900 | Right Ventricular Ejection Fraction, Cal (%) | RVEF_C | 2 | 70 | Visit 6 (1 Year) | 6 | 06APR2023 |
| 75 | -5 | -17.567568 | Decline >=5.0% |
|
|
...